Outcomes of advanced pulmonary large cell neuroendocrine carcinoma stratified by RB1 loss, SLFN11 expression, and tumor mutational burden.
JOURNAL OF CLINICAL ONCOLOGY
Authors: Sabari, Joshua K.; Julian, Ricklie Ann; Ni, Ai; Halpenny, Darragh; Hellmann, Matthew David; Drilon, Alexander E.; Li, Bob T.; Poirier, John T.; Rudin, Charles M.; Rekhtman, Natasha
Abstract
Measurement of SLFN11 protein in circulating tumor cells (CTCs) as a proposed liquid biopsy biomarker to predict response to DNA repair targeted therapies
EUROPEAN JOURNAL OF CANCER
Authors: Fernandez, L.; Chu, L.; Richardson, R.; Graf, R.; Wang, Y.; Landers, M.; Dittamore, R.
Abstract